Commercializing the Microbiome: Classic Bacterial Genetics Deployed to Treat Orphan Disease | McDermott Skip to main content

Commercializing the Microbiome: Classic Bacterial Genetics Deployed to Treat Orphan Disease

Commercializing the Microbiome: Classic Bacterial Genetics Deployed to Treat Orphan Disease

Overview


Kristina Bieker-Brady presents “Commercializing the Microbiome: Classic Bacterial Genetics Deployed to Treat Orphan Disease” at the Genetic Approaches to Understanding Complex Biological Problems at Princeton University.

Dig Deeper

Miami, FL / In-person / March 4-5, 2026

HPE Miami 2026

Webinar / Webinar / February 25, 2026

ISO 13485 Compliance for Medical Device Companies

Chicago, IL / Speaking Engagements / February 5, 2026

INTA Annual Case Law Review

San Francisco, CA / In-person / January 13, 2026

McDermott Forum at the 2026 J.P. Morgan Healthcare Conference